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Ruptured abdominal aortic aneurysm (AAA) is
an important and potentially preventable cause of
death. It has been known for 30 years that smoking
is a risk factor for AAA.1,2 However, few publica-
tions have studied in detail the association between
the duration of smoking, the amount smoked, and
the effect of stopping and the risk of aneurysm for-
mation. An association between the amount smoked
and the risk of AAA was recently confirmed,3 but
this was in a hospital-based study that compared
smokers with an aneurysm with smokers without an
aneurysm. A large cohort study found no relation-
ship between the amount smoked and the risk of
fatal AAA, although it was found that smokers of
hand-rolled cigarettes, in particular, had an
increased risk of dying of AAA.4
A more precise quantification of the association
between the risk of AAA and smoking, the duration
of smoking, the amount smoked, and the effect of
the cessation of smoking may lead to further
hypotheses about the definitive biologic mechanism
by which smoking causes aortic dilatation. The
destruction of elastin is thought to be the initiating
event in the pathogenesis of aortic aneurysms, with
subsequent widening of the aorta caused by the
haemodynamic stress being shifted on to collagen.5
A differential effect of smoking on small and large
aneurysms may indicate whether smoking affects
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Purpose: The purpose of this study was to investigate the precise effect of smoking, dura-
tion of smoking, and cessation of smoking on the risk of the development of an abdom-
inal aortic aneurysm (AAA).
Methods: A nested case control study was carried out in a population-based screening pro-
gram for men over the age of 50 years. Smoking data were collected by questionnaire, and
serum levels of cotinine were used as an objective measure of nicotine exposure.
Results: Data of 210 cases and 237 control individuals were analyzed. Current smokers
were 7.6 times more likely to have an AAA than nonsmokers (95% confidence interval,
3.3%-17.8%). Exsmokers were 3.0 times more likely to have an AAA than nonsmokers
(95% confidence interval, 1.4%-6.4%). Duration of smoking was significantly associated
with an increased risk of AAA, and there was a clear linear dose response relationship
with the duration of smoking; each year of smoking increased the relative risk of AAA
by 4% (95% confidence interval, 2%-5%). In contrast, the effect of the amount smoked
disappeared when an adjustment was made for the duration of smoking. After the ces-
sation of smoking, there was a very slow decline in the risk of the occurrence of an AAA.
Smoking was associated with a higher relative risk of a small aneurysm than a large
aneurysm. Serum cotinine levels were higher in men with a small aneurysm than in men
with a large aneurysm. Cotinine levels were similar in expanding aneurysms and stable
aneurysms.
Conclusion: The duration of exposure rather than the level of exposure appears to deter-
mine the risk of the development of an AAA in men older than 50 years. The slow
decline of risk after the cessation of smoking and the higher relative risk for small com-
pared with large aneurysms suggest that smoking is an initiating event for the condition.
(J Vasc Surg 1999;30:1099-1105.)
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mainly elastin or collagen function. Furthermore,
more precise information about the effects of smok-
ing may allow us to give better information to the
patients about the effects of smoking and the poten-
tial benefits of stopping.
METHODS 
A nested case control study was performed with-
in a population-based screening program for AAA
for men over the age of 50 years in Huntingdon,
UK. A nested case control study is defined as a study
in which the cases and control subjects were drawn
from the same cohort of screened men. This reduces
the effect of potential confounding variables.6
Definitions. A case was defined as a person with
an infrarenal aortic diameter exceeding 29 mm. Cases
were followed up with six monthly ultrasound scans
until the aortic diameter reached 45 mm at which
point they were referred to a vascular surgeon. A large
aneurysm was therefore arbitrarily defined as an
aneurysm that exceeded 40 mm. A control subject was
defined as a person with an infrarenal aortic diameter
less than 25 mm. Control subjects were matched for
age with frequency matching and selected at random
from the screened population with an aorta less than
25 mm in diameter. All subjects underwent at least
two measurements of their aortic diameter. 
Growth was calculated by dividing the difference
between the two diameters by the follow-up time in
years. Data about smoking status, smoking history,
family history of aortic aneurysm, occupational histo-
ry, previous medical history, and drug history were
obtained through a self-administered questionnaire.
Smoking status was classified into three categories:
current smokers, exsmokers and nonsmokers. Men
were classified as nonsmokers if they had never smoked
and as current smokers if they were still smoking. A
positive history of ischemic heart disease was recorded
if the patient had had a myocardial infarction, had
been admitted to hospital for treatment of angina, or
had undergone a coronary bypass operation. The pres-
ence of angina was diagnosed according to the Rose
questionnaire.7 The social class of the subject was
recorded on the basis of the main occupation of the
subject according to the Registrar General’s socioeco-
nomic grouping.8,9
Measurements. All men underwent a brief med-
ical examination by the same observer; the examina-
tion included measurements of height, weight, blood
pressure, and ankle brachial pressure index (ABPI). All
men were also examined for signs of unusual connec-
tive tissue function. Presence or absence of pes planus,
scoliosis, pectus deformities, flexible auricular carti-
lages, and Gorlings sign were combined with the
Beighton joint mobility score to form a connective tis-
sue laxity score.10
The infrarenal aortic diameter was measured by
the same ultrasonographer who used a Toshiba
Capasee with a curvilinear 3.5-MHz probe (Toshiba
Medical Systems Ltd, Crawley, United Kingdom).
Previous work performed by us has shown that the
limits of variability of the measurement of the
infrarenal aortic diameter are 5 mm.11 The measure-
ment of the aortic diameter was done after the med-
ical examination to prevent observer bias. 
The measurement of the ABPI was performed
with the patient in the supine position with a hand-
held Doppler scanner (Mini Dopplex D900;
Huntleigh Diagnostics, Cardiff, United Kingdom)
with an 8-MHz probe and a standard sphygmo-
manometer. The systolic brachial artery pressure was
recorded in both right and left arms. The higher of
the two pressures was used for the calculation of the
ABPI. The systolic ankle pressure was recorded at
the posterior tibial artery with the cuff of the sphyg-
momanometer immediately above the malleoli. The
ABPI was calculated for both legs, and the lowest
value was used to determine the presence of periph-
eral vascular disease. Peripheral vascular disease was
deemed present if the ABPI was lower than 0.8. 
At the time of the medical examination, a blood
sample was taken for the measurement of the serum
cotinine level with the use of a standard semiquantita-
tive microplate enzyme immunoassay (Cozart Bio-
sciences, Abingdon, United Kingdom). Cotinine lev-
els were used for a second, biochemical smoking clas-
sification. Patients were initially classified according to
the questionnaire data. Subjects with a serum cotinine
level exceeding 25 m g/L were classified as current
smokers.12 Subjects with a serum cotinine level below
25 m g/L were classified as either exsmokers or as non-
smokers, according to their questionnaire data.
Statistical analysis. Statistical analysis was per-
formed with unconditional logistic regression meth-
ods13 with STATA 5.0 for Macintosh (Stata Corp-
oration, College Station, Tex). Hypotheses were
tested by referring the log likelihood ratio to the chi-
squared distribution. 
RESULTS
Smoking status. Smoking data were available for
447 subjects: 237 control subjects and 210 cases. The
mean aortic diameter of the cases was 3.7 cm (SD, 0.7
cm) compared with 1.8 cm (SD, 0.3 cm) for control
subjects. The mean diameter of the entire screened
population was 2.1 cm (SD, 0.4 cm). The mean
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growth for the cases was 1.2 mm/y (SD, 3 mm) com-
pared with a mean growth per year of –0.5 mm (SD,
0.5 mm) for control subjects. The mean follow-up was
5 years for control subjects (range, 4-6 years) com-
pared with 2.5 years for cases (range, 0.4-5.7) The
average number of follow-up scans for the cases was 5. 
The frequency distribution of smoking status
according to age group is shown in Table I. There
were significantly more exsmokers in the older age
groups ( c 2 = 26.29 degrees of freedom (df); P <
.002). The observed differences between social class
of subject and smoking status are not statistically sig-
nificant (c 2 = 18.5, 18 df; P < .4). 
Relative risk of an aneurysm. Aneurysms were
more prevalent among current smokers and exsmokers
compared with nonsmokers. The observed differences
were highly significant (c 2 = 28.8, 3 df; P < .0001).
Smoking status was the variable most significant-
ly associated with an increased risk of an AAA. A
logistic regression model was used that adjusted for
all other relevant confounding variables (such as
family history of aneurysm, history of ischemic heart
disease, presence of peripheral vascular disease,
diuretic use, and a score for connective tissue laxity).
With this model, current smokers were 9 times more
likely to have an AAA compared with nonsmokers,
and exsmokers were 4 times more likely to have an
AAA compared with nonsmokers. The estimated rel-
ative risks were similar to those risks obtained with
the use of the biochemical classification of smokers
on the basis of cotinine levels (Table II). 
Association with duration of smoking
The average duration of smoking was 19 years.
Current smokers had smoked on average 50 years
(SD, 15 years), which was significantly longer than
the average of 30 years (SD, 15 years) for exsmok-
ers. The effect of duration of smoking on the risk of
an AAA is shown in Table III. There was a clear dose
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Table I. Smoking status and age*
Age (y)
Status 50-59 60-69 70-79 80-89 Total
Smoking cases
Nonsmoker (%) 1 2 1 0 5
Current smoker (%) 4 13 11 1 30
Exsmoker (%) 1 20 30 13 64
Missing (%) 0 0 0 0 1
Total (%) 7 36 43 15 210
Control subjects
Nonsmoker (%) 1 8 9 3 21
Current smoker (%) 2 7 5 0 14
Exsmoker (%) 4 22 27 10 63
Missing (%) 1 0 1 0 2
Total (%) 8 36 43 13 237
*Frequency distribution of smoking status according to 10-year age bands in 210 cases (AAA ‡ 3 cm) and 237 control subjects.
Table II. Relative risk of AAA by smoking status*
Variable Questionnaire Cotinine assay
Current smoker 9.0 (3.4-24.0) 7.6 (3.3-17.8)
Exsmoker 4.0 (1.6-9.5) 3.0 (1.4-6.4)
Missing 6.8 (1.0-47.0) NA
Nonsmoker 1.0 1.0
NA, Not applicable.
*Adjusted odds ratios of smoking categories compared with non-
smokers, adjusted for age, family history of AAA, history of
ischemic heart disease and treated hypertension connective tissue
laxity score, and presence of peripheral vascular disease with the
use of the best fitting logistic regression model. Classification into
smoking categories was made according to data from a self-admin-
istered questionnaire and according to a serum cotinine assay.
Values in parentheses are 95% CIs of the estimated relative risk.
Table III. Relative risk of AAA by duration of
smoking for all subjects*
Years smoked Odds ratio 95% CI
0 1.0 —
≤20 1.4 0.6-3.4
20-40 3.6 1.6-8.2
‡ 40 5.8 2.6-13
*Odds ratios of duration of smoking compared with non-smok-
ers, adjusted for age, family history of AAA, history of ischemic
heart disease and treated hypertension and presence of peripheral
vascular disease, using the best-fitting logistic regression model.
response relationship with duration of smoking (test
for trend, c 2 = 16.5, 1 df; P < .0001). Each year
smoked increased the relative risk by 4% (95% confi-
dence interval [CI], 2%-5%). The association
between the duration of smoking and AAA was ana-
lyzed separately for current smokers and exsmokers.
Each year of smoking was estimated to increase the
risk of AAA by 4%, (95% CI, –4%-12%) in current
smokers, compared with 3.8% for exsmokers (95%
CI, 1.7%-5.9%) and 3.8% for current and exsmokers
combined (95% CI, 2.1%-5.4%). 
The average age of starting to smoke was 18
years (range, 5-63 years). There was no difference in
starting age between current smokers and exsmok-
ers. More than 85% of subjects who had ever
smoked started smoking before the age of 21 years,
and 25% started before the age of 16 years. Age of
starting to smoke was not significantly associated
with increased risk of an AAA in a model where
duration of smoking was controlled for (c 2 = 0.89,
1 df; P = .35). 
Association with cessation of smoking. The
data of 383 current smokers and exsmokers were
analyzed for the effect of cessation of smoking on the
risk of AAA. The longer the period since cessation of
smoking, the smaller the risk of an AAA (Table IV; c 2
= 15.6, 4 df; P = .004). The decrease in relative risk
was similar in a model adjusted for the duration of
smoking, although this association was not signifi-
cant (c 2 = 1.31, 1 df; P = .86). The time since smok-
ing was stopped was associated with a reduction of
the risk of 4% per year (95% CI, 6%-2%) in a model
that did not include the duration of smoking (test for
trend, c 2 = 18, 1 df; P = .0001). In a model that
included both variables, the effects of the duration of
smoking and the time since cessation of smoking on
the risk of AAA were both halved. 
Association with amount smoked. The
amount smoked was estimated as packs of 20 ciga-
rettes per day. Current smokers and exsmokers both
smoked on average 0.8 packs per day (SD, 0.4). The
amount smoked was significantly associated with an
increased risk of an AAA (c 2 = 22.7, 5 df; P < .001),
and there was a clear dose response relationship
(Table V). Inclusion of the amount smoked as a con-
tinuous variable improved the model significantly
(c 2 = 15.3, 1 df; P = .0001). In a model that adjust-
ed for the duration of smoking, the association with
the amount smoked largely disappeared and failed to
reach statistical significance (c 2 = 1.8, 1 df; P < .18). 
Cotinine. Current smokers had a significantly
higher average cotinine level than exsmokers and
nonsmokers: 343 m g/L versus less than 10 m g/L for
nonsmokers and exsmokers. Three nonsmokers, 27
exsmokers, and 37 subjects with missing smoking
data were reclassified as current smokers if the serum
cotinine level was more than 25 m g/L. The relative
risks of an AAA for the biochemical smoking cate-
gories are shown in Table VI. The effect of the dura-
tion of smoking on the risk of AAA was exactly the
same as the increase estimated on the basis of the
questionnaire data; each year of smoking increased
the risk by 4% (95% CI, 3%-5%). The effect of the
cessation of smoking was also similar to the estimates
obtained from the questionnaire data. The main dif-
ference was that the relative risks decreased more
slowly with longer cessation of smoking, and a
decrease in the relative risk of an AAA decreased by
3% per year after the cessation of smoking in a model
that also adjusted for the duration of smoking.
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Table IV. Association with cessation of smoking*
Time since Adjusted for
smoking cessation duration Not adjusted
Currently smoking 1.0 1.0
1-5 y 0.65 (0.2;1.8) 0.62 (0.2;1.7)
6-10 y 0.55 (0.2;1.6) 0.47 (0.2;1.3)
11-20 y 0.88 (0.4;2.3) 0.61 (0.3;1.3)
21-30 y 0.50 (0.2;1.7) 0.28 (0.1;0.7)
>30 y 0.51 (0.1;2.5) 0.20 (0.1;0.4)
*Frequency distribution and relative risk of an AAA for time since
smoking cessation. Estimates are give adjusted for the duration of
smoking and not adjusted for the duration. Both models are
adjusted for age, family history of AAA, history of ischemic heart
disease and treated hypertension, and the presence of peripheral
vascular disease with the use of the best-fitting logistic regression
model. Values in parentheses are 95% confidence intervals of the
estimated relative risk.
Table V. Association with the amount smoked*
Amount smoked Unadjusted for Adjusted for
per day duration duration
0 1.0 1.0
1-5/d 2.1 (0.7;6.1) 0.8 (0.2;2.6)
6-10/d 5.1 (2.0;13.0) 1.9 (0.7;5.5)
11-15/d 3.4 (1.3;8.8) 1.1 (0.4;3.2)
16-20/d 4.2 (1.7;10.5) 1.1 (0.4;3.3)
>20/d 7.0 (2.7;18) 1.8 (0.6;5.8)
*Odds ratios for the average amount of cigarettes smoked relative
to nonsmokers, both unadjusted and adjusted for duration of
smoking. In both cases the same logistic regression model was
used that adjusted for age, family history of AAA, history of
ischemic heart disease and treated hypertension, and the presence
of peripheral arterial occlusive disease. Values in parentheses are
95% confidence intervals of the estimated relative risk.
The cases had significantly higher cotinine levels
than the control subjects. Expanders (defined as
aneurysms growing more than 2 mm per year) had
higher cotinine levels on average, but this was not
significant. Patients with small aneurysms had high-
er cotinine levels than patients with large aneurysms
(Table VI). 
Effects of smoking on small and large AAA.
The differential effects of smoking on small and large
AAA were analyzed separately. Data of 162 men with
a small AAA and of 48 men with a large AAA (diam-
eter, >4 cm) were available for analysis. Smoking was
associated with a higher increased relative risk of a
small aneurysm than a large aneurysm. This difference
remained if smokers were classified according to coti-
nine levels. The effects of the duration of smoking
and the amount smoked were stronger in the group
of small aneurysms compared with large aneurysms,
but these differences failed to reach statistical signifi-
cance (Table VII). The cessation of smoking had a
smaller effect on the risk of a large AAA. The relative
risk of a large AAA did not decrease in the first 10
years after the cessation of smoking. 
DISCUSSION
We have shown that smoking is associated with a
markedly increased risk of an AAA. Current smokers
are more than 7 times more likely to have an AAA than
age-matched nonsmokers. Exsmokers are 3 times
more likely to have an AAA compared with nonsmok-
ers. An increased duration of smoking was significant-
ly associated with an increased risk of AAA. There was
a clear linear dose response relationship with duration
of smoking and the period since smoking was stopped.
In contrast, the effect of the amount smoked disap-
peared when an adjustment was made for the duration
of smoking. There was a very slow decline in the risk
of an AAA after the cessation of smoking. 
The smoking-related increase in relative risk for
AAA is much larger than the increased relative risks
for coronary heart disease and peripheral vascular dis-
ease. In this study, we found a relative risk of angina
of 1.3 (95% CI, 0.6%-3.1%) for current smokers
compared with nonsmokers. The relative risk of
smoking for peripheral vascular disease was 3.7 (95%
CI, 1.2%-12%). The low relative risk for angina, how-
ever, could be caused by observation bias; patients
with coronary heart disease are more likely to stop
smoking. The relative risk estimated on the basis of
our data is lower than the estimates from 10 large
cohort studies that found that smoking doubles the
risk of coronary heart disease.14 It seems likely that
the effect of smoking on the risk of aneurysms is larg-
er than the effect of smoking on the risk of both
coronary heart disease and peripheral vascular dis-
ease, especially because our estimate of the effect of
smoking on the risk of an aneurysm is similar to the
estimates from two large cohort studies.2,4
Our estimates are robust. Selection bias has been
minimized because the control subjects have been
randomly selected from the same population-based
cohort from which the cases originated. Observation
bias could be a confounding factor because subjects
diagnosed with a vascular disease are more likely to
stop smoking. This clearly affected the association we
found between smoking and angina and may be a par-
tial explanation for the lower average cotinine levels
found in patients with large aneurysms. We believe,
however, it is not a major source of bias in our esti-
mates of the relationship between smoking and
aneurysms, because differential cessation of smoking
in the cases would lead to a conservative bias on the
risk. Smoking is a negative confounder because the
number of current smokers decreases with increasing
age although the risk of AAA increases with advanc-
ing age. Furthermore, 64% of subjects were exsmok-
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Table VI. Serum cotinine levels*
Mean cotinine 
Category level (m g/L) 95% CI
Normal (< 2.5 cm; n = 237) 52 32;72
All aneurysms (‡ 3 cm; n = 210) 109 83;134
Small AAA (n = 162) 123 92;154
Large AAA (‡ 4 cm; n = 48) 66 24;107
Expanding AAA (n = 47) 112 56;169
Stable AAA (n = 400) 112 81;141
*Average serum cotinine levels in micrograms per liter for differ-
ent categories of aneurysms. An expanding AAA is defined as an
aneurysm that has grown more than 2 mm per year.
Table VII. Differential effects of smoking on
small and large aneurysms*
Relative risk for Relative risk for
Variable large AAA small AAA
Current smokers 5.8 (1.0;34.0) 12.2 (4.4;34.0)
Exsmokers 4.2 (0.9;19.0) 3.9 (1.6;9.8)
Serum cotinine > 25 m g/L 2.4 (0.6;9.5) 10.7 (4.2;27.0)
Serum cotinine < 25 m g/L 2.0 (0.6;6.4) 3.3 (1.4;8.0)
Duration of smoking 2.0 (0.3;5.0) 3.4 (0.5;4.5)
*Relative risks and 95% CI of those persons at risk from various
smoking exposures for a large AAA (diameter, ‡ 4 cm) and a small
AAA (diameter, > 2.9 and < 4.0 cm). Values in parentheses are
95% confidence intervals of the estimated relative risk.
ers, and more than 60% of those had stopped before
the screening project started. Misclassification is not a
major confounder because the estimates changed only
marginally when the analysis was done on the basis of
cotinine levels. Recall bias is unlikely to be significant
because smoking was very common among subjects
of this age group, and there is no reason to assume
differential bias in the recollection of smoking habits
among cases and control subjects. 
Confounding by other variable has been mini-
mized by including them in the logistic regression
model. For instance, the finding that the association
with the amount smoked disappeared when the
duration of exposure was taken into account sug-
gests that the duration rather than the amount
smoked is crucial. A large part of the increase in the
incidence of aneurysms with age could be explained
by the strong effect of the duration of smoking.
Finally, it is unlikely that these findings are a result of
a chance occurrence because estimates of the same
magnitude were found when the analysis was per-
formed separately for current smokers or exsmokers.
A striking finding was the slow decline in relative
risk after the cessation of smoking, especially for large
aneurysms. In contrast, patients who stop smoking
reduce their risk of myocardial infarction by up to 50%
at 1 year, and their risk approaches that of those who
never smoked after 10 years.15-17 Furthermore, smok-
ing was associated with a larger relative risk for having
a small aneurysm compared with a large aneurysm.
This is confirmed by our finding that cotinine levels
were higher in patients with a small AAA compared
with those with a large aneurysm. Finally, cotinine lev-
els were the same in patients with an expanding
aneurysm compared with those with a stable
aneurysm, which may indicate that factors other than
smoking become important once the initial dilatation
of the aorta has occurred. The difference in relative
risk associated with smoking between patients with
large and small aneurysms and the lower cotinine lev-
els in patients with large aneurysms can be explained
by the fact that patients stop smoking when they are
diagnosed with an aneurysm or heart disease. It is
unlikely that this observation bias is the sole cause for
the larger effect of smoking on the risk of small
aneurysms compared with large aneurysms, because
there are three times more exsmokers than current
smokers in the group we used for our analysis of the
effect of the cessation of smoking. Furthermore, more
than 60% of exsmokers gave up smoking before the
screening project was started. 
The finding of a slow decline in relative risk and
a differential effect of smoking on small and large
aneurysms suggests that smoking is an important
initiating factor in the development of aneurysms.
This suggests that smoking affects mainly elastin
degradation. This has been confirmed in studies of
the effect of smoking in emphysema.18 Smoking
may lose some of its importance once significant
widening has occurred, and the structural integrity
of collagen becomes more important for the further
expansion of aneurysms.
CONCLUSION
Smoking was the most important risk factor for
aortic aneurysms. The duration of exposure rather
than the level of exposure determines the risk of the
ment of aneurysms. The slow decline of risk after the
cessation of smoking and the differential relative risk
for small compared with large aneurysms would sug-
gest that smoking mainly affects elastin function.
We thank Nichola Lovell for supervising the screening
program and Chris Marshall (Department of Chemical
Pathology, Hinchingbrooke Hospital) for the analysis of
the cotinine assays.
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